Literature DB >> 23405351

Draft Genome Sequences of Pseudomonas fluorescens BS2 and Pusillimonas noertemannii BS8, Soil Bacteria That Cooperate To Degrade the Poly-γ-d-Glutamic Acid Anthrax Capsule.

Richard A Stabler1, David Negus, Arnab Pain, Peter W Taylor.   

Abstract

A mixed culture of Pseudomonas fluorescens BS2 and Pusillimonas noertemannii BS8 degraded poly-γ-d-glutamic acid; when the 2 strains were cultured separately, no hydrolytic activity was apparent. Here we report the draft genome sequences of both soil isolates.

Entities:  

Year:  2013        PMID: 23405351      PMCID: PMC3569354          DOI: 10.1128/genomeA.00057-12

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Experimental infections caused by bacteria that elaborate a polysaccharide or polypeptide capsule can be resolved by administration of capsule hydrolases that strip away the protective capsular layer from the bacterial surface (1, 2). Anthrax is an excellent candidate for this approach: the inhalational form of the infection requires prompt therapy, and the causative agent, Bacillus anthracis, invariably expresses a unique poly-γ-d-glutamic acid (PDGA) capsule that is necessary for optimal pathogenesis (3). If successful, the capsule-stripping approach could confound attempts to render anthrax untreatable by the engineering of multidrug-resistant strains for unlawful dissemination. The poly-γ-glutamate-specific capsule depolymerase (CapD) produced by B. anthracis removes the capsule from the surface of the anthrax bacillus (4) and can protect against anthrax infection (5) but is markedly unstable (6) and therefore unlikely to be useful for therapeutic development. We have recently obtained a highly stable PDGA-specific capsule depolymerase from bacterial cultures (unpublished data); soil enrichment techniques were employed to isolate bacteria with the capacity to degrade PDGA and to use the hydrolytic products as the sole source of carbon and energy. The most pronounced hydrolytic activity was associated with a strongly mutualistic consortium culture comprising two morphologically distinct colony types; when the two strains were cultured separately, no depolymerase activity was apparent in either culture. A 16S sequence identified these organisms as Pseudomonas fluorescens (s_ab score = 1) and Pusillimonas noertemannii (s_ab score = 0.996). The two isolates, P. fluorescens BS2 and P. noertemannii BS8, were sequenced in order to provide a database for the identification of the PDGA depolymerase and to provide a platform for elucidation of the basis of interstrain cooperation. Only one Pusillimonas species genome sequence, from an oil-degrading bacterium isolated from the Bohai Sea, is currently available (7). Whole-genome sequencing was performed on the Illumina HiSeq 2000 platform using a single read (read 1) from a paired-end read library with read lengths of 100 bp. The short sequence reads were first processed with Trimmomatic (8) and quality assessed using FastQC (http://www.bioinformatics.babraham.ac.uk//projects/fastqc/) software. VelvetOptimiser (http://bioinformatics.net.au/software.velvetoptimiser.shtml) was used for optimization of the Velvet de novo assembly (9), resulting in 122 contigs with an N50 of 5,355 bp for P. fluorescens BS2, comprising in total 6,123,259 bp, and 121 contigs with an N50 of 15,214 bp for P. noertemannii BS8, comprising in total 3,916,977 bp. Automated gene prediction and annotation were performed using RAST (10), which predicted 5,539 and 3,633 coding sequences for P. fluorescens BS2 and P. noertemannii BS8, respectively. Interestingly, RAST indicated that the nearest neighbor to P. fluorescens BS2 was P. fluorescens SBW25 and to P. noertemannii BS8 was Bordetella bronchiseptica RB50.

Nucleotide sequence accession numbers.

The Pseudomonas fluorescens BS2 and Pusillimonas noertemannii BS8 sequences have been deposited in NCBI under accession numbers AMZF00000000 and AMZG00000000. Short reads have been deposited in the SRA under accession number SRA058672.
  9 in total

1.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

2.  Complete genome sequence of Pusillimonas sp. T7-7, a cold-tolerant diesel oil-degrading bacterium isolated from the Bohai Sea in China.

Authors:  Boyang Cao; Ting Ma; Yan Ren; Yi Ren; Guoqiang Li; Ping Li; Xi Guo; Peng Ding; Lu Feng
Journal:  J Bacteriol       Date:  2011-05-27       Impact factor: 3.490

Review 3.  Anthrax.

Authors:  M Mock; A Fouet
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

4.  Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis.

Authors:  Angelo Scorpio; Donald J Chabot; William A Day; David K O'brien; Nicholas J Vietri; Yoshifumi Itoh; Mansour Mohamadzadeh; Arthur M Friedlander
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

5.  Treatment of experimental anthrax with recombinant capsule depolymerase.

Authors:  Angelo Scorpio; Steven A Tobery; Wilson J Ribot; Arthur M Friedlander
Journal:  Antimicrob Agents Chemother       Date:  2007-12-26       Impact factor: 5.191

6.  Improvement of a potential anthrax therapeutic by computational protein design.

Authors:  Sean J Wu; Christopher B Eiben; John H Carra; Ivan Huang; David Zong; Peixian Liu; Cindy T Wu; Jeff Nivala; Josef Dunbar; Tomas Huber; Jeffrey Senft; Rowena Schokman; Matthew D Smith; Jeremy H Mills; Arthur M Friedlander; David Baker; Justin B Siegel
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

7.  RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics.

Authors:  Marc Lohse; Anthony M Bolger; Axel Nagel; Alisdair R Fernie; John E Lunn; Mark Stitt; Björn Usadel
Journal:  Nucleic Acids Res       Date:  2012-06-08       Impact factor: 16.971

8.  Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype.

Authors:  Naseem Mushtaq; Maria B Redpath; J Paul Luzio; Peter W Taylor
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

  9 in total
  4 in total

1.  Genome Mining and Predictive Functional Profiling of Acidophilic Rhizobacterium Pseudomonas fluorescens Pt14.

Authors:  Pooja Rani; Nitish Kumar Mahato; Anukriti Sharma; Desiraju Lakshmi Narsimha Rao; Komal Kamra; Rup Lal
Journal:  Indian J Microbiol       Date:  2017-04-18       Impact factor: 2.461

2.  Parenteral Administration of Capsule Depolymerase EnvD Prevents Lethal Inhalation Anthrax Infection.

Authors:  David Negus; Julia Vipond; Graham J Hatch; Emma L Rayner; Peter W Taylor
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

3.  3-Hydroxypyridine Dehydrogenase HpdA Is Encoded by a Novel Four-Component Gene Cluster and Catalyzes the First Step of 3-Hydroxypyridine Catabolism in Ensifer adhaerens HP1.

Authors:  Haixia Wang; Xiaoyu Wang; Hao Ren; Xuejun Wang; Zhenmei Lu
Journal:  Appl Environ Microbiol       Date:  2020-09-17       Impact factor: 4.792

4.  Characterisation of Bacteriophage-Encoded Depolymerases Selective for Key Klebsiella pneumoniae Capsular Exopolysaccharides.

Authors:  George Blundell-Hunter; Mark C Enright; David Negus; Matthew J Dorman; Gemma E Beecham; Derek J Pickard; Phitchayapak Wintachai; Supayang P Voravuthikunchai; Nicholas R Thomson; Peter W Taylor
Journal:  Front Cell Infect Microbiol       Date:  2021-06-18       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.